CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice--clinical implications for CCR5 inhibition as antiretroviral therapy.
Stefan
S
Mauss
Massimo
M
Puoti
D000818:Animals; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000378:metabolism; D003208:Concanavalin A; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D019713:Receptors, CCR5 / Q000172:deficiency* / Q000235:genetics; D013601:T-Lymphocytes
D044966:Anti-Retroviral Agents; D019713:Receptors, CCR5; D003208:Concanavalin A